Determination of Regulatory Review Period for Purposes of Patent Extension; TEPEZZA

Summary

The Food and Drug Administration (FDA) has determined the regulatory review period for the patent extension of TEPEZZA, a human biological product, following a submission to the U.S. Patent and Trademark Office (USPTO). This determination is being published as required by law.